Friday, March 11, 2011

Average Salary Of Ccie In India

GEITDAH CONSENSUS on attention deficit disorder / hyperactivity

consists


Francisco Montanes-Rada, Xavier Gastaminza-Pérez, Miguel A. Catala, Francisco Ruiz-Sanz, Pedro M. Ruiz-Lazaro, Oscar Herrera-Rodríguez, Marta García-Giral, Juan Ortiz-Guerra, José A. Alda-Díez, Dolores Mojarro-Práxedes, Tom Sang-Díez, María J. Mardomingo-Sanz, Jordi Sasot-Llevadot, Montserrat Pàmias, Francisco Rey-Sanchez.


The GEITDAH, Special Interest Group on Attention Deficit Disorder / Hyperactivity Disorder (ADHD), introduced in this article published last November 16, 2010: A committee of experts from all over Spain on the management of ADHD. Agreement was reached on basic issues that should be the starting point for future local or regional consensus. A further aim of this consensus reducing variations in care that occurs in our country to ADHD and provide a stimulus for learning. Its small size will allow wider dissemination, in order to achieve these ends more effectively. The conclusions of the consensus have been structured around an introduction to basic aspects and recommendations for diagnosis, treatment (pharmacological and psychotherapeutic), flow patients and organizational issues.
GEITDAH Consensus on ADHD Introduction for ADHD diagnosis requires the presence of
inattention and / or hyperactivity
e
impulsivity, which affects the functioning of the sufferer in various areas of your life. Some people are predominantly hyperactive and impulsive, while others are predominantly inattentive.
Some of the manifestations of
Diagnosis Screening for ADHD should be part of the psychopathological assessment of every patient.
The assessment of ADHD requires a clinical interview with the patient and, where appropriate, parents / family / spouse and reports of other observers, including teachers, etc. The information to be obtained includes the possible existence of problems in the family, school, work and social, as well as the evaluation of personal and family medical history. tests, scales and questionnaires are an aid does not replace the clinical interview.
not require additional tests (laboratory, neurological, radiological, etc..) Where the personal or family medical history is normal.
psychological tests are necessary if cognitive deficits seen or low yields.
should evaluate possible
comorbid disorders (oppositional defiant disorder, conduct disorder, anxiety, tics, etc.)..
Before establishing a drug treatment should be considered:
cardiac rating if cardiovascular personal or family history (especially dyspnea moderate to severe stress syncope, sudden death, heart palpitations or disorders heart rate).
Heart Rate Monitoring and blood pressure. This should be done well after each change of treatment and at least every six months.
Risk of abuse or misuse of the drug.
  • Evaluation of the presence of symptoms or psychiatric disorders may be caused or exacerbated by drugs (periodic inspection).
  • Diagnosis and patient flow
  • diagnosis and treatment of ADHD and comorbid must be supervised by a physician with expertise in ADHD.
  • If the level of involvement is mild or moderate, you should start, at least, a psychoeducational approach.
    If problems persist after 10 weeks, assessing the referral to specialized care.
  • If the degree of impairment is severe, you should refer to specialized care.
treatment in primary care should be performed according to established protocols with local specialized care.
Referral to specialized care from the school for counseling teams that have evaluated the child, will be made through primary care.
The treatment of children under six years and nonresponders in another health care is a criterion for referral to specialized care.
Treatment
should develop a treatment plan individualized and interdisciplinary.
treatment should include a comprehensive program for patients and their environment, including at least
school and parents. This plan must address the psychological difficulties and educational / occupational .
Drug therapy is the first choice in severe cases, also offered to non-responders or partial responders to other therapies from 6 years. Pharmacological treatment in children under 6 years must lead to specialized care.
The combination of evidence-based psychotherapy and psychotropic drugs is the most effective treatment.
therapy is applied must be based on evidence. At present, behavioral therapy or cognitive behavior is the one that has shown greater support.
The first choice pharmacological treatment is methylphenidate. choice is atomoxetine in patients who respond to methylphenidate in high doses or with intolerance in moderate doses, and patients with tics worsen with methylphenidate. At least once a year, should assess the need to continue treatment.
organizational aspects
The public health system has to provide and secure the resources needed for the treatment of ADHD for children and adolescents and adults.
Similarly, public systems have to offer training programs for teachers and parents to enable a basic level of detection and behavioral interventions in their spheres of influence.
talk
of the diagnosis, ruling out the recommendation not to screening in the general population, leaving the local context the recommendation.
The statement that "the tests and scales do not replace the interview" was completed, to explain in another recommendation, when psychological tests are indeed necessary.
also qualified their part concerning neurological and laboratory tests.
specification was discarded that physicians are experts in ADHD neurologists and psychiatrists, and that drug treatment should begin as they left open the type of treatment that should be implemented by experts
and not just limited to drugs.
It has avoided a specialist referral algorithm
(
proposed a similar to the NICE guidance) and therefore does not specify at what time or what severity or circumstances has to derive from primary to specialized care or how to derive from psychoeducational counseling teams. This, in part, is due to the high standards of derivation proposed by the NICE guideline
: is derived from primary after a period of 10 weeks if no response psychoeducational intervention in mild-moderate (bass and children under 6 years specialist is derived directly.) An example of the objections raised was that the psychoeducational intervention can not be performed in primary care in our country.
also dismissed for failing to offer workable and inconvenient, as proposed by NICE guidance, treatment group as the default form of care, individual therapy reserved for specific cases and the cognitive-behavioral for severe cases only.
was discarded drugs that can be used are only those approved by U.S. drug agencies (FDA) and European (EMEA), for obvious and effect size data of various drugs. It dismissed the creation of the guardian's case, but added the need to treat the child's environment.
generally rejected the argument that in which the working group considered that lacked adequate scientific evidence and chose different options, those with more scientific evidence. hope this guide easy to standardize on minimum standards, care for patients with ADHD, and may be modified as needed locally. It plans to review every two years or the appearance of new evidence to justify its modification. To read the full article: http://www.neurologia.com/pdf/Web/5110/be100633.pdf

0 comments:

Post a Comment